Skip to content

Fidelity MSCI Health Care Index ETF

FHLCNYSE ArcaA

$81.73−1.12 (−1.35%)

At close: Oct 13, 2026, 4:00 PM

Intraday session: down, 79 prints from 82.85 to 81.73. Range 81.69 to 82.98. Use the arrow keys to read each point.82.0082.2582.5083.0010 AM12 PM2 PM4 PM
Expense ratio
0.08%
Fund size
$3.5B
1Y total return
+23.1%
Yield · Last 12 months
1.23%
Holdings
345
Avg volume · 30D
0.2M sh
NAV per share
$82.87
52W range
low $67.77high $85.46
Launched
Filings
SEC EDGAR

The ETF.net FHLC Grade

A

Score 84 out of 100

Rank
1 of 25
Six-pillar profile for FHLC. Scores out of 100: Cost 98, Risk 80, Mission 81, Tradability 84, Holdings 57, Durability 77. Strongest: Cost (98). Weakest: Holdings (57). Leans toward Cost.

Score 84 of 100 falls in the A band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    A98 out of 100
    Rank 1 of 25
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    A81 out of 100
    Rank 2 of 11
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    A80 out of 100
    Rank 1 of 24
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    A84 out of 100
    Rank 4 of 25
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    B57 out of 100
    Rank 15 of 25
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    A77 out of 100
    Rank 6 of 25

Our read on FHLC

ETF.net Research

AHealth care, whole market. FHLC tracks an MSCI index that runs from mega-cap pharma down to small-cap biotech and device makers, roughly 400 names, for 0.08% a year.

Stated mandate

The fund seeks to track the performance of the MSCI USA IMI Health Care Index before fees and expenses.

Why people hold it

  1. 01Charges 0.08% a year against a 0.50% median for broad health care ETFs. Only XLV matches that sticker; VHT sits a hair above.
  2. 02The IMI index it follows reaches for about 99% of US free-float market value, so smaller biotech and device names ride along with the pharma giants.msci.com
  3. 03Mirrors its benchmark closely, one of the tighter tracking jobs among broad health care funds. Distributions come quarterly.
  4. 04Fidelity has run it since 2013, and it has grown into a multi-billion-dollar fund with a plain vanilla index mandate.institutional.fidelity.com

Worth knowing

  1. 01One sector, one country. Drug-pricing politics, patent cliffs and FDA rulings move the whole portfolio at once.
  2. 02Free-float cap weighting means a handful of mega-cap insurers and drugmakers carry most of the weight; that long tail of small names counts for less than it looks.msci.com
  3. 03Moderately traded rather than the category's volume leader, so spreads matter more on large or hurried orders.

FHLC Holdings

As of Oct 13, 2026
Asset class
Stocks
Holdings
345
Top-10 weight
52%
Largest holding
LLY13.0%

Sectors

  • Health Care99.3%
  • Technology0.6%
  • Financials0.0%

Geography

  • United States97.30%
  • Ireland2.14%
  • United Kingdom0.37%
  • Canada0.07%
  • Switzerland0.07%
  • Netherlands0.04%
The fund’s holdings, weight-ordered — page 1 of 23.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001LLYEli Lilly & Co13.05%404,931$478M583
002JNJJohnson & Johnson8.70%1,217,710$318M528
003ABBVAbbVie Inc6.75%893,743$247M522
004MRKMerck & Co Inc New4.97%1,249,387$182M515
005UNHUnitedHealth Group Inc4.76%459,389$174M481
006TMOThermo Fisher Scientific Inc3.38%187,993$124M375
007AMGNAmgen Inc3.09%273,009$113M491
008GILDGilead Sciences Inc2.59%628,056$95M492
009ABTAbbott Laboratories2.40%881,110$88M376
010PFEPfizer Inc2.23%2,883,127$82M378
011—Securities Lending Cf2.14%78,173,968$78M51
012ISRGIntuitive Surgical Inc2.08%179,161$76M410
013DHRDanaher Corp1.94%322,232$71M331
014VRTXVertex Pharmaceuticals Inc1.79%128,397$65M422
015BMYBristol-Myers Squibb Co1.67%1,032,998$61M463

Showing 1–15 of 345 holdings

FHLC Performance

Launched Oct 21, 2013

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

FHLC$12,312
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. FHLC $12,312. SPY $12,044. Use the arrow keys to read each point.$9,537$11,193$12,849Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for FHLC. Periods over one year show the average yearly return.
PeriodFHLC
Year to date+12.7%
1 month+3.5%
3 months+6.0%
1 year+23.1%
3 yearsper year+12.7%
5 yearsper year+7.2%
10 yearsper year+11.2%

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for FHLC
YearReturn barFHLC
2026 YTD+12.7%
2025+15.4%
2024+2.5%
2023+2.6%
2022−5.5%
2021+20.4%
2020+18.2%

FHLC in the news

Filtered to FHLC · Health Care (Broad)

FHLC Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 12, 2026.
1.23%Last 12 months
Payout per share
$1.02Last 12 months
Last payment
$0.25 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution history

2017–2026

One bar per payment. 40 payments from 2017 to 2026 YTD. Mar 17, 2017 $0.13; Jun 16, 2017 $0.14; Sep 15, 2017 $0.13; Dec 15, 2017 $0.16; Mar 16, 2018 $0.13; Jun 15, 2018 $0.15; Sep 21, 2018 $0.14; Dec 21, 2018 $0.15; Dec 28, 2018 $0.32; Mar 15, 2019 $0.16; Jun 21, 2019 $0.16; Sep 20, 2019 $0.17; Dec 20, 2019 $0.09; Mar 20, 2020 $0.25; Jun 19, 2020 $0.17; Sep 18, 2020 $0.18; Dec 18, 2020 $0.23; Mar 19, 2021 $0.20; Jun 18, 2021 $0.18; Sep 17, 2021 $0.19; Dec 17, 2021 $0.22; Mar 18, 2022 $0.22; Jun 17, 2022 $0.20; Sep 16, 2022 $0.22; Dec 16, 2022 $0.19; Mar 17, 2023 $0.23; Jun 16, 2023 $0.23; Sep 15, 2023 $0.22; Dec 15, 2023 $0.22; Mar 15, 2024 $0.24; Jun 21, 2024 $0.24; Sep 20, 2024 $0.25; Dec 20, 2024 $0.26; Mar 21, 2025 $0.25; Jun 20, 2025 $0.26; Sep 19, 2025 $0.26; Dec 19, 2025 $0.27; Mar 20, 2026 $0.23; Jun 18, 2026 $0.26; Sep 18, 2026 $0.25. Use the arrow keys to read each point.2017201820192020202120222023202420252026YTD
Ex-datePay dateAmount per share
Sep 18, 2026Sep 22, 2026$0.25
Jun 18, 2026Jun 23, 2026$0.26
Mar 20, 2026Mar 24, 2026$0.23
Dec 19, 2025Dec 23, 2025$0.27
Sep 19, 2025Sep 23, 2025$0.26
Jun 20, 2025Jun 24, 2025$0.26
Mar 21, 2025Mar 25, 2025$0.25
Dec 20, 2024Dec 24, 2024$0.26
Sep 20, 2024Sep 24, 2024$0.25
Jun 21, 2024Jun 25, 2024$0.24
Mar 15, 2024Mar 20, 2024$0.24
Dec 15, 2023Dec 20, 2023$0.22

FHLC Risk

How much the fund’s monthly returns vary, scaled to a year.
14.2%
Annualised · 36 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.56
vs 3-month T-bills · to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−17.7%
Trough Jun 2022
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.59
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FHLC Cost

Expense ratio0.08%
  • The middle half of Health Care (Broad) funds
  • Median 0.50%

No Health Care (Broad) fund charges less.

FHLC costs $8.00 a year on $10,000. The median Health Care (Broad) fund costs $50.00.

Other funds in Health Care (Broad)